13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001600004
申报总市值
US$16.5亿
US$16.5亿
36 檔
24.2%
Q4 2024 季度申报显示，First Light Asset Management, LLC 披露的美股组合总市值为 US$16.5亿，涵盖 36 个不同之权益投资仓位。
在 Q4 2024，First Light Asset Management, LLC 展现出较为审慎的避险与获利了结姿态。本季共减仓 18 个仓位并完全清仓 11 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，First Light Asset Management, LLC 的前 5 大核心持股（包含 FNAUSD, 260, AXGN 等）合计占整体申报市值的 24.2%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FNAUSD | Paragon 28 Inc | 股票-其他 | 10.46% | — | +4.19% | |
| 2 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 9.30% | -5.56% | EXIT | |
| 3 | AXGN | Axogen Inc | 股票-其他 | 7.11% | -4.16% | +10.18% | |
| 4 | ATRC | Atricure Inc | 股票-其他 | 5.76% | -0.90% | +5.56% | |
| 5 | TWST | Twist Bioscience CORP | 股票-其他 | 5.45% | +0.81% | — | |
| 6 | VERA | Vera Therapeutics Inc | 股票-其他 | 5.10% | -1.13% | EXIT | |
| 7 | NEO | Neogenomics Inc | 股票-医疗保健 | 4.99% | +4.42% | +2.96% | |
| 8 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 4.35% | — | -1.78% | |
| 9 | CRNX | Crinetics Pharmaceuticals In | 股票-其他 | 4.33% | -0.45% | -6.16% | |
| 10 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 3.71% | -0.57% | — | |
| 11 | HCAT | Health Catalyst Inc | 股票-其他 | 3.55% | +0.08% | +21.99% | |
| 12 | PFMTUSD | Performant Financial CORP | 股票-其他 | 3.28% | — | +1.22% | |
| 13 | INSM | Insmed Inc | 股票-医疗保健 | 3.11% | — | -31.75% | |
| 14 | MDXG | Mimedx Group Inc | 股票-其他 | 3.08% | -1.01% | EXIT | |
| 15 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 3.07% | — | +1.13% | |
| 16 | KRMD | Koru Medical Systems Inc | 股票-其他 | 2.18% | -0.60% | +5.65% | |
| 17 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 2.12% | — | -34.73% | |
| 18 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.99% | -0.13% | — | |
| 19 | JANX | Janux Therapeutics Inc | 股票-其他 | 1.61% | — | — | |
| 20 | SIBN | Si-bone Inc | 股票-其他 | 1.53% | +2.00% | -25.50% | |
| 21 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 1.48% | — | -5.67% | |
| 22 | NTRA | Natera Inc | 股票-医疗保健 | 1.41% | — | -49.67% | |
| 23 | BFLY | Butterfly Network Inc | 股票-其他 | 1.19% | +0.39% | — | |
| 24 | RGEN | Repligen CORP | 股票-医疗保健 | 1.14% | — | -50.29% | |
| 25 | ANAB | Anaptysbio Inc | 股票-其他 | 1.10% | -0.42% | -8.36% | |
| 26 | GPCR | Structure Therapeutics Inc | 股票-其他 | 1.03% | — | -21.21% | |
| 27 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 1.01% | +0.84% | -71.51% | |
| 28 | DYN | Dyne Therapeutics Inc | 股票-其他 | 0.95% | — | -66.56% | |
| 29 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 0.92% | — | — | |
| 30 | GH | Guardant Health Inc | 股票-医疗保健 | 0.90% | +1.71% | -52.33% | |
| 31 | PODD | Insulet CORP | 股票-医疗保健 | 0.84% | — | -78.74% | |
| 32 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 0.83% | — | -47.41% | |
| 33 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 0.70% | — | -69.03% | |
| 34 | SENS1GBP | Senseonics Holdings Inc | 股票-其他 | 0.32% | — | — | |
| 35 | EVH | Evolent Health Inc - A | 股票-其他 | 0.06% | — | -97.67% | |
| 36 | IWO | Ishares Russell 2000 Growth | ETF-中小型股 | 0.03% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | TWST | Twist Bioscience CORP | +5.5% | NEW | 新建仓 |
| 2 | FNAUSD | Paragon 28 Inc | +4.8% | +4.19% | 加仓 |
| 3 | IRTC | Irhythm Holdings Inc | +3.7% | NEW | 新建仓 |
| 4 | MDXG | Mimedx Group Inc | +3.1% | NEW | 新建仓 |
| 5 | VERA | Vera Therapeutics Inc | +2.5% | +78.84% | 加仓 |
| 6 | AXGN | Axogen Inc | +2.3% | +10.18% | 加仓 |
| 7 | EWTX | Edgewise Therapeutics Inc | +2% | NEW | 新建仓 |
| 8 | JANX | Janux Therapeutics Inc | +1.6% | NEW | 新建仓 |
| 9 | ATRC | Atricure Inc | +1.4% | +5.56% | 加仓 |
| 10 | 260 | Centessa Pharmaceuticals-adr | +1.4% | -2.27% | 减仓 |
| 11 | NEO | Neogenomics Inc | +1.2% | +2.96% | 加仓 |
| 12 | BFLY | Butterfly Network Inc | +1.2% | NEW | 新建仓 |
| 13 | ELDN | Eledon Pharmaceuticals Inc | +0.9% | NEW | 新建仓 |
| 14 | KRMD | Koru Medical Systems Inc | +0.9% | +5.65% | 加仓 |
| 15 | HCAT | Health Catalyst Inc | +0.6% | +21.99% | 加仓 |
| 16 | XENE | Xenon Pharmaceuticals Inc | +0.5% | -1.78% | 减仓 |
| 17 | SENS1GBP | Senseonics Holdings Inc | +0.3% | NEW | 新建仓 |
| 18 | CRNX | Crinetics Pharmaceuticals In | +0.3% | -6.16% | 减仓 |
| 19 | IWO | Ishares Russell 2000 Growth | 0% | NEW | 新建仓 |
| 20 | ✓ | 0% | EXIT | 清仓 | |
| 21 | ATEC | Alphatec Holdings Inc | -0.1% | EXIT | 清仓 |
| 22 | KYMR | Kymera Therapeutics Inc | -0.1% | -5.67% | 减仓 |
| 23 | PFMTUSD | Performant Financial CORP | -0.2% | +1.22% | 加仓 |
| 24 | SIBN | Si-bone Inc | -0.3% | -25.50% | 减仓 |
| 25 | PLRX | Pliant Therapeutics Inc | -0.3% | -34.73% | 减仓 |
| 26 | GH | Guardant Health Inc | -0.3% | -52.33% | 减仓 |
| 27 | EXK | Exact Sciences CORP | -0.4% | EXIT | 清仓 |
| 28 | RARE | Ultragenyx Pharmaceutical In | -0.4% | +1.13% | 加仓 |
| 29 | NTRA | Natera Inc | -0.5% | -49.67% | 减仓 |
| 30 | NARIUSD | Inari Medical Inc | -0.6% | EXIT | 清仓 |
| 31 | ASND | Ascendis Pharma A/S | -0.6% | EXIT | 清仓 |
| 32 | MOH | Molina Healthcare Inc | -0.8% | EXIT | 清仓 |
| 33 | AVTR | Avantor Inc | -0.8% | EXIT | 清仓 |
| 34 | GPCR | Structure Therapeutics Inc | -0.8% | -21.21% | 减仓 |
| 35 | RGEN | Repligen CORP | -0.9% | -50.29% | 减仓 |
| 36 | RLAY | Relay Therapeutics Inc | -0.9% | EXIT | 清仓 |
| 37 | INSM | Insmed Inc | -1.1% | -31.75% | 减仓 |
| 38 | OPRX | Optimizerx CORP | -1.2% | EXIT | 清仓 |
| 39 | ANAB | Anaptysbio Inc | -1.5% | -8.36% | 减仓 |
| 40 | BCYC | Bicycle Therapeutics Plc-adr | -1.8% | EXIT | 清仓 |
| 41 | PODD | Insulet CORP | -2.2% | -78.74% | 减仓 |
| 42 | OSCR | Oscar Health Inc - Class A | -2.4% | -69.03% | 减仓 |
| 43 | TNDM | Tandem Diabetes Care Inc | -2.6% | -71.51% | 减仓 |
| 44 | PPHMEUR | Avid Bioservices Inc | -2.6% | EXIT | 清仓 |
| 45 | TMDX | Transmedics Group Inc | -2.6% | -47.41% | 减仓 |
| 46 | DYN | Dyne Therapeutics Inc | -2.8% | -66.56% | 减仓 |
| 47 | EVH | Evolent Health Inc - A | -5.4% | -97.67% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，First Light Asset Management, LLC 在 Q4 2024 季度的美股持仓总市值约为 US$16.5亿，共申报了 36 个公开持股仓位。
在 Q4 2024 季度，First Light Asset Management, LLC 按市值排列的前三大核心持股分别为：FNAUSD (10.5%)、260 (9.3%)、AXGN (7.1%)。其中最大持股仓位 FNAUSD 占据整体投资组合约 10.5% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
TWST
市值: US$5698.4万
本季最大获利了结 / 清仓标的
PPHMEUR
前期市值: US$3154.4万
在 Q4 2024 季度中，First Light Asset Management, LLC 共进行了 47 项持仓异动，包含新建仓 9 个仓位、加仓 9 个仓位、减仓 18 个仓位以及清仓 11 个仓位。 其中最大新建仓标的为 TWST。 本季清仓仓位包含 PPHMEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。